Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust: Accumbens mglu2/3 generate valence
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Glutamatergic inputs to the nucleus accumbens (NAc) modulate both appetitive and fearful motivation. It has been suggested that pathological disturbances of glutamate signaling in NAc contribute to motivation disorders, ranging from excessive desire in drug addiction to paranoia in schizophrenia. Metabotropic glutamate receptors are of special interest, as metabotropic Group II receptor (mglu2/3) agonists have been proposed as potential treatments for both addiction and schizophrenia. Here we tested whether local mglu2/3 receptor blockade in the medial shell of the rat NAc can generate intense distortions of motivation or affect, which might model clinical dysfunction. We found that microinjection of the mglu2/3 antagonist LY341495 at sites throughout medial shell suppressed appetitive motivation to eat and drink. Simultaneously, LY341495 microinjections generated fearful motivation in the form of defensive treading or burying. To assess whether the valence shift extended into a parallel hedonic shift from affective 'liking' to 'disliking' we employed the taste reactivity test, which measures affective orofacial reactions to the sensory pleasure or displeasure of tastes. We found that LY341495 microinjections reduced positive 'liking' reactions to sucrose and enhanced 'disliking' reactions. Overall, mglu2/3 antagonism at most shell sites produced a similar valence shift from positive to negative. This pattern comprised (i) generation of fearful behaviors, and (ii) induction of aversive affective reactions, together with (iii) loss of appetitive ingestion and (iv) loss of 'liking' for rewards. These results are discussed in terms of implications for clinical disorders and the influence of corticolimbic glutamate inputs to NAc in the generation of motivation and affect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Self-citationKapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813 · cited 2×
“generated in part by NAc circuits, is involved in the paranoia of human schizophrenia (Kapur, 2003; Barch, 2005; Taylor et al., 2005; Kienast & Heinz, 2006; Schmidt & Beninger, 2006; Jensen et al., 2008; Walter et al., 2010).”
BackgroundThe Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · cited 2×
“…has been proposed by Kapur and others to be the mechanism of action of typical and atypical antipsychotic medications, which block D2 dopamine receptors to prevent the enhancement of salience of negative stimuli (Kapur & Mamo, 2003; Kapur, 2004; Howes & Kapur, 2009; Heinz & Schlagenhauf, 2010).”
BackgroundThe debate over dopamine’s role in reward: the case for incentive salience
Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347
Self-citationIkemoto, S., & Panksepp, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00023-5 · Cited by 1,450
The glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350 · cited 2×
“Disruptions of glutamate signaling are implicated in a variety of motivation disorders including addiction, depression and schizophrenia (Moghaddam, 2004; Lapish et al., 2006; Uys & LaLumiere, 2008; Floresco et al., 2009; Guo et al., 2009; Kalivas, 2009).”
BackgroundPatil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Cortico-Basal Ganglia Reward Network: Microcircuitry
Sesack, S. R., & Grace, A. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.93 · Cited by 985 · cited 1×
“…behaviors such as reward seeking (Ikemoto & Panksepp, 1999; Cardinal & Everitt, 2004; Kalivas & Volkow, 2005; Kelley et al., 2005; Nicola, 2007; Sesack & Grace, 2010), but it also plays a role in negatively valenced motivation and affect, such as fear, pain, stress and disgust (Blackburn et…”
BackgroundMesolimbocortical and nigrostriatal dopamine responses to salient non-reward events
Horvitz, J. C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00019-1 · Cited by 967
Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
Cartmell, J., & Schoepp, D. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750889.x · Cited by 883
Cited by
Supra-Additive Effects of Combining Fat and Carbohydrate on Food Reward
DiFeliceantonio, A. G., Coppin, G., Rigoux, L., Edwin Thanarajah, S., Dagher, A., Tittgemeyer, M., & Small, D. M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.018 · Cited by 296
Peciña, S., & Berridge, K. C. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12174 · Cited by 216
“Fos plume diameter data were integrated with behavioral effect data produced at microinjection sites to create function maps similarly to our previous studies (Peci~na & Berridge, 2000, 2005; Smith & Berridge, 2005; Reynolds & Berridge, 2008; Richard & Berridge, 2011).”
BackgroundMethodInfluentialSelf-citationMapping brain circuits of reward and motivation: In the footsteps of Ann Kelley
Richard, J. M., Castro, D. C., DiFeliceantonio, A. G., Robinson, M. J. F., & Berridge, K. C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.008 · Cited by 177
Self-citationCurrent perspectives on incentive salience and applications to clinical disorders
Olney, J. J., Warlow, S. M., Naffziger, E. E., & Berridge, K. C. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.01.007 · Cited by 157
Self-citationThe dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.
Liggins, J., Pihl, R. O., Benkelfat, C., & Leyton, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028370 · Cited by 58
Metadata
- Authors
- Richard, J. M., & Berridge, K. C.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2010-12-29
- Volume
- 33
- Issue
- 4
- Pages
- 736-747
- ISSN
- 0953-816X (ISSN-L)
- OpenAlex
- W2131422183
- Cited by
- 45
- References
- 38
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust: Accumbens mglu2/3 generate valence. https://app.cochat.ai/papers/10.1111/j.1460-9568.2010.07553.x
- The paper
- Richard, J. M., & Berridge, K. C. (2011). Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust: Accumbens mglu2/3 generate valence. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2010.07553.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.